Home Cart Sign in  
Chemical Structure| 29479-00-3 Chemical Structure| 29479-00-3

Structure of Tabersonine HCl
CAS No.: 29479-00-3

Chemical Structure| 29479-00-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Tabersonine Hydrochloride is an indole alkaloid with effects on improving Aβ aggregation and anti-inflammatory activity, used in neurodegenerative disease research.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Tabersonine HCl

CAS No. :29479-00-3
Formula : C21H25ClN2O2
M.W : 372.89
SMILES Code : [H][C@]12N3CC=C[C@@]1(CC)CC(C(OC)=O)=C4[C@]2(CC3)C5=CC=CC=C5N4.[H]Cl
MDL No. :MFCD02258999
InChI Key :BBASQSWPQOKOQI-OCIDDWSYSA-N
Pubchem ID :12443187

Safety of Tabersonine HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
THP-1 cells 10 μM 3 h Inhibited IL-1β production Acta Pharmacol Sin. 2023 Jun;44(6):1252-1261.
Bone marrow-derived macrophages (BMDMs) 0.71 μM 30 min Inhibited NLRP3-mediated IL-1β production and suppressed NLRP3 inflammasome assembly Acta Pharmacol Sin. 2023 Jun;44(6):1252-1261.
Saccharomyces cerevisiae 40 µM 48 h To test the epoxidation activity of PYS1 on tabersonine, it was found that PYS1 could convert tabersonine into pachysiphine. Plant J. 2024 Dec;120(5):1880-1900.
Nicotiana benthamiana 100 µM 24 h To test the epoxidation activity of PYS1 and PYS2 on tabersonine, it was found that PYS1 and PYS2 could convert tabersonine into pachysiphine. Plant J. 2024 Dec;120(5):1880-1900.
HS633T cells 10 µM 24 h To investigate the effects of Tabersonine on ONNV-infected human fibroblast cells, results showed that Tabersonine could inhibit viral replication and modulate the host cell immune response. Pharmaceuticals (Basel). 2023 Aug 9;16(8):1125.
osteoblasts 5 or 10 µM 24 h Tabersonine increased cell viability and alkaline phosphatase (ALP) activity, and reduced the mitochondrial superoxide, reactive oxygen species and matrix metalloproteinase levels and osteoblast apoptosis. AMB Express. 2020 Sep 11;10(1):165.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Peritonitis, acute lung injury, and sepsis models Gavage 10, 20, or 40 mg/kg Single administration Significantly ameliorated NLRP3-driven diseases such as peritonitis, acute lung injury, and sepsis Acta Pharmacol Sin. 2023 Jun;44(6):1252-1261.
Rats Dexamethasone-induced osteoporosis model Intraperitoneal injection 20 or 40 mg/kg Once daily for 60 days Tabersonine ameliorated dexamethasone-induced osteoporosis by regulating the Nrf2/ROS/Bax signaling pathway, reduced trabecular destruction and increased bone synthesis. AMB Express. 2020 Sep 11;10(1):165.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.68mL

0.54mL

0.27mL

13.41mL

2.68mL

1.34mL

26.82mL

5.36mL

2.68mL

 

Historical Records

Categories